Tortoise Investment Management’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-726
Closed -$13.5K – 1216
2025
Q3
$13.5K Buy
726
+8
+1% +$149 ﹤0.01% 573
2025
Q2
$13.2K Buy
718
+9
+1% +$160 ﹤0.01% 568
2025
Q1
$12.4K Buy
709
+9
+1% +$152 ﹤0.01% 560
2024
Q4
$12.1K Buy
700
+500
+250% +$9.13K ﹤0.01% 603
2024
Q3
$3.72K Hold
200
– – ﹤0.01% 711
2024
Q2
$3.08K Hold
200
– – ﹤0.01% 726
2024
Q1
$2.95K Buy
200
+100
+100% +$1.39K ﹤0.01% 723
2023
Q4
$1.43K Hold
100
– – ﹤0.01% 729
2023
Q3
$1.39K Buy
+100
New +$1.28K ﹤0.01% 727

Other funds holding SBRA

Tortoise Investment Management's SBRA Position: Q4 2025 in Review

Tortoise Investment Management sold out of Sabra Healthcare REIT (SBRA) in Q4 2025, closing a stake of 726 shares — an estimated $13.5K sold.

Tortoise Investment Management first reported a position in SBRA in Q3 2023 and held it in 9 quarters. The position peaked at $13.5K in Q3 2025. 441 funds tracked by Wall St. Rank hold SBRA as of Q4 2025.

  • Tortoise Investment Management reported no remaining Sabra Healthcare REIT position as of Q4 2025 after selling out during the quarter.
  • Tortoise Investment Management sold 726 Sabra Healthcare REIT shares in Q4 2025, an estimated $13.5K.
  • Tortoise Investment Management first reported a position in Sabra Healthcare REIT in Q3 2023 and held it in 9 quarters.
  • Tortoise Investment Management's Sabra Healthcare REIT position peaked at $13.5K in Q3 2025.
  • 441 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q4 2025.

Based on Tortoise Investment Management's 13F filing for Q4 2025, filed 6 Feb 2026.